Cargando…
Stanniocalcin-1 Is an Ocular Hypotensive Agent and a Downstream Effector Molecule That Is Necessary for the Intraocular Pressure–Lowering Effects of Latanoprost
PURPOSE: To identify downstream signaling molecules through which intraocular pressure (IOP) is lowered following treatment with the prostaglandin analog latanoprost. METHODS: Total RNA and protein isolated from primary human Schlemm's canal cells (n = 3) treated with latanoprost (free acid; 10...
Autores principales: | Roddy, Gavin W., Viker, Kimberly B., Winkler, Nelson S., Bahler, Cindy K., Holman, Bradley H., Sheikh-Hamad, David, Roy Chowdhury, Uttio, Stamer, W. Daniel, Fautsch, Michael P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444548/ https://www.ncbi.nlm.nih.gov/pubmed/28538979 http://dx.doi.org/10.1167/iovs.16-21004 |
Ejemplares similares
-
Stanniocalcin-1 (STC-1), a downstream effector molecule in latanoprost signaling, acts independent of the FP receptor for intraocular pressure reduction
por: Roddy, Gavin W., et al.
Publicado: (2020) -
Effect of ATP-sensitive Potassium Channel Openers on Intraocular Pressure in Ocular Hypertensive Animal Models
por: Roy Chowdhury, Uttio, et al.
Publicado: (2022) -
Effect of Cromakalim Prodrug 1 (CKLP1) on Aqueous Humor Dynamics and Feasibility of Combination Therapy With Existing Ocular Hypotensive Agents
por: Roy Chowdhury, Uttio, et al.
Publicado: (2017) -
Ocular Hypotensive Properties and Biochemical Profile of QLS-101, a Novel ATP-Sensitive Potassium (K(ATP)) Channel Opening Prodrug
por: Pervan-Steel, Cynthia L., et al.
Publicado: (2022) -
Transgene expression of Stanniocalcin-1 provides sustained intraocular pressure reduction by increasing outflow facility
por: Roddy, Gavin W., et al.
Publicado: (2022)